Aspira Women's Health Inc. (AWHL)
OTCMKTS · Delayed Price · Currency is USD
0.2222
+0.0125 (5.94%)
At close: Aug 12, 2025
Aspira Women's Health Revenue
Aspira Women's Health had revenue of $2.28M in the quarter ending March 31, 2025, with 5.85% growth. This brings the company's revenue in the last twelve months to $9.31M, up 3.53% year-over-year. In the year 2024, Aspira Women's Health had annual revenue of $9.18M with 0.31% growth.
Revenue (ttm)
9.31M
Revenue Growth
+3.53%
P/S Ratio
0.85
Revenue / Employee
141.03K
Employees
66
Market Cap
7.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.18M | 28.00K | 0.31% |
| Dec 31, 2023 | 9.15M | 970.00K | 11.85% |
| Dec 31, 2022 | 8.18M | 1.37M | 20.14% |
| Dec 31, 2021 | 6.81M | 2.16M | 46.46% |
| Dec 31, 2020 | 4.65M | 113.00K | 2.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
Aspira Women's Health News
- 4 weeks ago - Aspira Women's Health Announces Appointment of Jane Pine Wood to the Board of Directors - Accesswire
- 2 months ago - Aspira Women's Health Partners with Dorsata to Offer Access to 300+ Women's Health Practices, 1.5 Million + New Patients - Accesswire
- 2 months ago - Aspira Women's Health Provides Update on ARPA-H Sprint Program Partnership to Advance Women's Health - Accesswire
- 3 months ago - Aspira Announces First Quarter 2025 Financial Results and Provides Business Update - Accesswire
- 3 months ago - Aspira Successfully Completes Application to the OTCQB - Accesswire
- 3 months ago - Aspira Reaches Another ARPA-H Milestone, Eligible to Receive Additional $1.5 Million in Second Quarter - Accesswire
- 4 months ago - Aspira Women's Health Inc. to Begin Trading April 17th On OTC Under the Symbol "AWHL" - Accesswire
- 4 months ago - Aspira Women's Health Inc. Announces Receipt of Delisting Notification from Nasdaq - Accesswire